Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
GlucoTrack, Inc.

GlucoTrack, Inc. (GCTK) Stock Overview

Explore GlucoTrack, Inc.’s financial performance, market position, analyst ratings, and future outlook.

GCTK●NASDAQ
HealthcareMedical - Instruments & Supplies
$0.29
$0.02(6.76%)
U.S. Market opens in 14h 26m

GlucoTrack, Inc. (GCTK)

Meyka AI Score

Z

Key Financials

Market Cap165.2K
P/E Ratio-0.05
EPS (TTM)$-20.89
ROE-5.82%
Fundamental Analysis

AI Price Forecasts

1 Month$-2.35
3 Months$15.41
1 Year Target$0.00

GCTK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of GlucoTrack, Inc. (NASDAQ: GCTK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, GlucoTrack, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GCTK on the NASDAQ shows an RSI of 34.69, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind GlucoTrack, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.05 and a market capitalization of 165.2K. Combined with our AI analysis, these give both institutional and retail investors a clear view of GCTK on the NASDAQ.

Price Performance (NASDAQ: GCTK)

1-Day Change
-6.76%
5-Day Change
-43.87%
1-Month Change
-16.80%
3-Month Change
-60.29%
6-Month Change
-91.96%
Year-to-Date (YTD) Change
-92.48%
1-Year Change
-96.20%
3-Year Change
-99.99%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.glucotrack.com
972 8 675 7878
301 Route 17 North, Rutherford, NJ, 7760049

Company Facts

150 Employees
IPO DateApr 25, 2013
CountryUS
Actively Trading

Frequently Asked Questions